Keyword lacasse activity

back to newsletters

Displaying 1 - 2 of 2 newsletters tagged with this topic.

Download PDF


In this issue two articles were submitted by a team of researchers based in the University of Catania (Italy) focused on the potential use of mushroom nutrition in neurodegenerative disease. The basis for hypothesis is due to the enzyme activity that offsets the reactive oxygen species associated with the onset of Parkinson’s, Alzheimer´s disease and ALS.

The articles are:
Mushroom Nutrition as a Target for Novel Therapeutic Strategies: Relevance to Nutritional Approaches and Antioxidant Redox Modulation in Ant-Ageing Medicine- Professor Vittorio Calabrese et al.

Comparative Enzyme Analysis of Polyporus umbellatus, Agaricus blazei, Pleurtous osteratus and Hericium erinaceus-Carolin Cornelius et al.

This issue closes with a poster presentation entitled:
Coriolus versicolor Supplementation as Immunonutrition in HPV Patients with Cervical Lesions (LSIL)-by Dr. Jose Silva Couto-Institute of Oncology, Coimbra Portugal.

The poster is an evaluation of the efficacy of Coriolus versicolor supplementation in patients infected with HPV with low-grade squamous intraepithelial lesions (LSIL). The article describes how Coriolus versicolor supplementation (3g /day) over a period of one year substantially increased regression of the dysplasia (LSIL) and induced clearance of the high risk sub-types of the HPV virus responsible for cervical cancer.

read more
Download PDF


In this seventh edition, we present the results of Dr. Julian Kenyon's 30 patient observational study on the use of Coriolus versicolor supplementation in Stage III and Stage IV cancer patients in which he measures the changes in telomerase activity, interleukin 5, interleukin 12 and Tumor Necrosis Factor Beta over 120 days. In addition two case studies on the use of Coriolus in Ulcerative Colitis and Crohn´s disease are provided. Additionally, a case study on the use of Coriolus versicolor in breast cancer is presented. Finally, Dr. Amin Karmali suggests that the biomass form of mushroom nutrition may be a form of enzyme therapy that could have applications in cancer care.

read more